{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:03:18Z","timestamp":1787508198996,"version":"build-2736575974"},"reference-count":17,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","primary-care-diabetes.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Primary Care Diabetes"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.pcd.2015.06.003","type":"journal-article","created":{"date-parts":[[2015,7,2]],"date-time":"2015-07-02T14:15:15Z","timestamp":1435846515000},"page":"156-159","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Investigating incretin-based therapies as a novel treatment for depression in type 2 diabetes: Findings from the South London Diabetes (SOUL-D) Study"],"prefix":"10.1016","volume":"10","author":[{"given":"C.D.","family":"Moulton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.C.","family":"Pickup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.A.","family":"Amiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Winkley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pcd.2015.06.003_bib0090","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.2337\/dc08-0985","article-title":"Depression and type 2 diabetes over the lifespan: a meta-analysis","volume":"31","author":"Mezuk","year":"2008","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.pcd.2015.06.003_bib0095","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.2337\/diacare.28.11.2668","article-title":"The association of comorbid depression with mortality in patients with type 2 diabetes","volume":"28","author":"Katon","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pcd.2015.06.003_bib0100","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/00006842-200107000-00015","article-title":"Association of depression and diabetes complications: a meta-analysis","volume":"63","author":"de Groot","year":"2001","journal-title":"Psychosom. Med."},{"issue":"10","key":"10.1016\/j.pcd.2015.06.003_bib0105","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1001\/archpsyc.61.10.1042","article-title":"The Pathways Study: a randomized trial of collaborative care in patients with diabetes and depression","volume":"61","author":"Katon","year":"2004","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pcd.2015.06.003_bib0110","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.2337\/dc13-2522","article-title":"The association between depressive symptoms and systemic inflammation in people with type 2 diabetes: findings from the South London Diabetes Study","volume":"37","author":"Laake","year":"2014","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.pcd.2015.06.003_bib0115","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/nrendo.2009.48","article-title":"Incretin-based therapies for type 2 diabetes mellitus","volume":"5","author":"Lovshin","year":"2009","journal-title":"Nat. Rev. Endocrinol."},{"issue":"9","key":"10.1016\/j.pcd.2015.06.003_bib0120","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1210\/jc.2012-1544","article-title":"Sitagliptin exerts an anti-inflammatory action","volume":"97","author":"Makdissi","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.pcd.2015.06.003_bib0125","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1253\/circj.CJ-12-1168","article-title":"Dipeptidyl peptidase-4 inhibitor, sitagliptin, improves endothelial dysfunction in association with its anti-inflammatory effects in patients with coronary artery disease and uncontrolled diabetes","volume":"77","author":"Matsubara","year":"2013","journal-title":"Circ. J."},{"issue":"7","key":"10.1016\/j.pcd.2015.06.003_bib0130","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/j.1463-1326.2010.01196.x","article-title":"Patient-reported outcomes following treatment with the human GLP-1 analogue liraglutide or glimepiride in monotherapy: results from a randomized controlled trial in patients with type 2 diabetes","volume":"12","author":"Bode","year":"2010","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.pcd.2015.06.003_bib0135","series-title":"Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications, Report of a WHO Consultation","author":"World Health Organisation","year":"1999"},{"issue":"6","key":"10.1016\/j.pcd.2015.06.003_bib0140","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1007\/s00125-013-2873-5","article-title":"The clinical characteristics at diagnosis of type 2 diabetes in a multi-ethnic population: the South London Diabetes cohort (SOUL-D)","volume":"56","author":"Winkley","year":"2013","journal-title":"Diabetologia"},{"issue":"8","key":"10.1016\/j.pcd.2015.06.003_bib0145","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1097\/PSY.0b013e3182a2b108","article-title":"Comparison of depressive symptoms in type 2 diabetes using a two-stage survey design","volume":"75","author":"Twist","year":"2013","journal-title":"Psychosom. Med."},{"issue":"1\u20133","key":"10.1016\/j.pcd.2015.06.003_bib0150","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jad.2010.04.030","article-title":"Defining successful treatment outcome in depression using the PHQ-9: a comparison of methods","volume":"127","author":"McMillan","year":"2010","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pcd.2015.06.003_bib0155","series-title":"British National Formulary, September 2014\u2013March","year":"2015"},{"issue":"5","key":"10.1016\/j.pcd.2015.06.003_bib0160","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s10557-013-6463-z","article-title":"Glucagon-like peptide-1 receptor agonist liraglutide inhibits endothelin-1 in endothelial cell by repressing nuclear factor-kappa B activation","volume":"27","author":"Dai","year":"2013","journal-title":"Cardiovasc. Drugs Ther."},{"issue":"9","key":"10.1016\/j.pcd.2015.06.003_bib0165","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.metabol.2014.06.004","article-title":"Effects of sitagliptin therapy on markers of low-grade inflammation and cell adhesion molecules in patients with type 2 diabetes","volume":"63","author":"Tremblay","year":"2013","journal-title":"Metabolism"},{"issue":"3","key":"10.1016\/j.pcd.2015.06.003_bib0170","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1007\/s11033-012-2290-8","article-title":"GLP-1-dependent and independent effects and molecular mechanisms of a dipeptidyl peptidase 4 inhibitor in vascular endothelial cells","volume":"40","author":"Hu","year":"2013","journal-title":"Mol. Biol. Rep."}],"container-title":["Primary Care Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1751991815000881?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1751991815000881?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T23:55:40Z","timestamp":1761695740000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1751991815000881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S1751991815000881"],"URL":"https:\/\/doi.org\/10.1016\/j.pcd.2015.06.003","relation":{},"ISSN":["1751-9918"],"issn-type":[{"value":"1751-9918","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigating incretin-based therapies as a novel treatment for depression in type 2 diabetes: Findings from the South London Diabetes (SOUL-D) Study","name":"articletitle","label":"Article Title"},{"value":"Primary Care Diabetes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcd.2015.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown copyright \u00a9 2015 Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}